NTLA vs. SE
NTLA (Intellia Therapeutics, Inc.) and SE (Sea Limited) are both stocks. NTLA operates in Biotechnology (Healthcare), while SE operates in Electronic Gaming & Multimedia (Communication Services). Over the past 5 years, NTLA returned -40.39%/yr vs -17.31%/yr for SE. Their 0.34 correlation means their historical movements had little consistent relationship.
Performance
NTLA vs. SE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NTLA achieves a 18.80% return, which is significantly higher than SE's -16.33% return.
NTLA
- 1D
- -3.70%
- 1M
- -39.18%
- 6M
- -18.78%
- YTD
- 18.80%
- 1Y
- -7.05%
- 3Y*
- -36.11%
- 5Y*
- -40.39%
- 10Y*
- -5.06%
- ALL TIME*
- -6.82%
SE
- 1D
- 0.47%
- 1M
- 3.33%
- 6M
- -8.37%
- YTD
- -16.33%
- 1Y
- -30.78%
- 3Y*
- 17.43%
- 5Y*
- -17.31%
- 10Y*
- —
- ALL TIME*
- 23.92%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $37.16M | $55.27M | $78.35M | |
| $416.43M | $503.28M | $427.19M |
NTLA vs. SE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NTLA Intellia Therapeutics, Inc. | 18.80% | -22.90% | -61.76% | -12.61% | -70.49% | 117.35% | 270.82% | 7.47% | -28.98% | -31.48% |
SE Sea Limited | -16.33% | 20.24% | 161.98% | -22.16% | -76.74% | 12.39% | 394.90% | 255.30% | -15.08% | -17.97% |
Correlation
The correlation between NTLA and SE is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.19 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.35 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2017 | 0.34 |
The correlation between NTLA and SE shifts across timeframes, from 0.19 (3 years) to 0.35 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
NTLA:
$1.20B
SE:
$64.08B
NTLA:
-$3.51
SE:
$2.53
NTLA:
18.16
SE:
2.70
NTLA:
2.04
SE:
5.28
NTLA:
$66.09M
SE:
$25.19B
NTLA:
-$33.92M
SE:
$11.15B
NTLA:
-$299.32M
SE:
$2.33B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NTLA vs. SE — Risk / Return Rank
NTLA
SE
NTLA vs. SE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Intellia Therapeutics, Inc. (NTLA) and Sea Limited (SE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NTLA | SE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.54 | ||
| Sortino ratioReturn per unit of downside risk | +1.32 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 0.91 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | -0.53 | +0.41 |
| Martin ratioReturn relative to average drawdown | -0.17 | -0.79 | +0.62 |
Loading charts...
Drawdowns
NTLA vs. SE - Drawdown Comparison
The maximum NTLA drawdown since its inception was -96.45%, which is greater than SE's maximum drawdown of -90.51%. Use the drawdown chart below to compare losses from any high point for NTLA and SE.
Loading charts...
Drawdown Indicators
| NTLA | SE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.45% | -90.51% | -5.94% |
Max Drawdown (1Y)Largest decline over 1 year | -71.27% | -60.22% | -11.05% |
Max Drawdown (3Y)Largest decline over 3 years | -84.31% | -60.22% | -24.09% |
Max Drawdown (5Y)Largest decline over 5 years | -96.45% | -90.51% | -5.94% |
Max Drawdown (10Y)Largest decline over 10 years | -96.45% | — | — |
Current DrawdownCurrent decline from peak | -93.96% | -70.91% | -23.05% |
Average DrawdownAverage peak-to-trough decline | -57.56% | -44.53% | -13.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 48.81% | 40.54% | +8.27% |
Volatility
NTLA vs. SE - Volatility Comparison
Intellia Therapeutics, Inc. (NTLA) has a higher volatility of 18.85% compared to Sea Limited (SE) at 11.04%. This indicates that NTLA's price experiences larger fluctuations and is considered to be riskier than SE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NTLA | SE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.85% | 11.04% | +7.81% |
Volatility (6M)Calculated over the trailing 6-month period | 56.80% | 39.24% | +17.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 98.08% | 51.46% | +46.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.01% | 64.24% | +13.77% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 78.82% | 62.35% | +16.47% |
Dividends
NTLA vs. SE - Dividend Comparison
Neither NTLA nor SE has paid dividends to shareholders.
Financials
NTLA vs. SE - Financials Comparison
This section allows you to compare key financial metrics between Intellia Therapeutics, Inc. and Sea Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NTLA and SE have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NTLA has higher volatility (18.85%) compared to SE (11.04%). In terms of maximum drawdown, NTLA dropped -96.45% vs SE's -90.51%.
NTLA currently has the higher Sharpe Ratio (-0.08 vs -0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NTLA and SE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer